Bioscience Business and Marketing Essentials, Thursday and Friday, Oct. 7-8, 2010
2-Day Intensive Course: Bioscience Business and Marketing Essentials, Thursday and Friday, Oct. 7-8, 2010 with 2 months to complete project
Lead Instructor: Audrey S. Erbes, Ph.D., Principal, Erbes & Associates and www.audreysnetwork.com
Expert Guest Speakers:
Donald Holsten, Pharm. D., Regulatory Consultant and Educator
Bev Hudson, MBA, Senior Vice President, Business Development, OmniComm Systems, Inc
Julie Tompkins, MBA, Senior Vice President, Timely Data Resources (TDR)
Please see www.ucsc-extension.edu/BBME for details
Date & Time: Oct. 7-8, 2010, Thursday and Friday, 8:30am-5pm
Location: UCSC Extension in Silicon Valley, 2505 Augustine Drive, Santa Clara, CA 95053
Fee: $800; $720 through Sept. 23
Topic Description
The bioscience industry is like no other. Lengthy timelines and unique financial, legal, regulatory, social and political challenges impose constraints that impact every aspect of the business. This course helps participants gain: a practical understanding of the bioscience industry landscape, key business drivers and challenges; insight into the critical roles that business and marketing disciplines play at all stages of a bioscience company's development; and hands-on experience implementing important bioscience business processes that are essential to success within the industry. Two days of intensive classroom are followed by 2 months to complete individual project with guidance of instruction and access to research resources. For more information: See course listed under certificate program at www.ucsc-extension.edu/biobusiness.
Instructor:
Audrey Erbes, Ph.D., Principal, Erbes & Associates, is a marketing professional with more than 25 years of managerial experience in marketing and business development in the biotech and pharmaceutical industry. She is also a recognized speaker and industry blogger at www.audreysnetwork.com. She was Executive Vice President and cofounder of Kowa Research Institute, a biopharmaceutical licensing and investment subsidiary of Kowa Company Ltd., Japan. Prior to that, she held man¬agement positions at Syntex Corp. (acquired by Roche) in market research, product management, strategic marketing and planning, and business development in the U.S. and abroad, with a special emphasis on Europe and Asia/Pacific/Canada.
Guest Speakers:
Donald Holsten, Pharm D., a regulatory consultant and educator with over 20 years of national and international experience as a senior regulatory affairs and quality assurance executive, has expertise in food, drug/biopharmaceutical, medical device and cosmetic products. He has an intimate knowledge of the FDA approval cycle and has helped prepare numerous biotechnology and pharmaceutical companies for FDA interactions and panel reviews. Don has held management positions at several companies, including Liposome Technology, Inc and Oclassen Pharmaceuticals, Inc. where he was Director of Regulatory Affairs/Quality Assurance and Director of Regulatory Affairs, respectively. Earlier in his career he held a senior level position as Assistant Chief, Food and Drug Branch, Department of Health Services for the State of California. Topic: "Operating in the U.S. Regulatory Environment: Is Product Approvable."
Bev Hudson, M.B.A., is the senior vice president, Business Development, OmniComm Systems, Inc., a Web-based electronic data capture (EDC) and eClinical (eClinical) software and services company with products that streamline the clinical research process. Previously, she was VP and General Manager of Clinical Research Services at MedPoint Communications, Inc. and earlier ran sales and operations for Mayo Clinical Trial Services. She spent eleven years at Genentech in sales and marketing management roles. Topic: "The Impact of U.S. Health Care System on Marketing Biotech Products."
Julie Tompkins, M.B.A., is senior vice president at Timely Data Resources (TDR), a healthcare market research and consulting firm. She has nearly 30 years experience in the pharmaceutical and biotech arenas, including more than 12 years in industry and more than 20 years in market research consulting, and has worked with pharmaceuticals, diagnostics, and drug delivery systems. At Syntex (now Roche), Julie worked in both R&D and Marketing. After leaving Syntex, Julie was President and Founder of MedSearch, a primary market research company that merged with TDR in January 2000. Topic: "The Role of Market Research in Product Planning, Development and Marketing".
